We no longer support this version of your browser.
We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.
Stop Gliptins in Patients Admitted With Heart Failure
See updated information from the FDA concerning heart failure risk with saxagliptin and alogliptin You'll see new warnings about a possible increased risk of heart failure with saxagliptin (Onglyza, etc) and alogliptin (Nesina, etc). ...